Akanda Corp. (NASDAQ:
AKAN
), an international medical cannabis company, has recently disclosed its participation in a registered direct offering priced at the Minimum Price under Nasdaq rules. The company has entered into a securities purchase agreement with an accredited investor for the acquisition of 2,491,381 common shares at a purchase price of $0.1031. Additionally, the investor will obtain 21,756,922 pre-funded warrants to purchase 21,756,922 common shares at $0.103 per share.
The pre-funded warrants are immediately exercisable at an exercise price of $0.0001 and are subject to certain beneficial ownership limitations as outlined in the pre-funded warrant.
Technical Outlook
Akanda Corp. (NASDAQ:
AKAN
) stock is up 24.98% as of the time of writing with a bullish Relative Strength Index (RSI) of 66.87 which is slightly overbought. The stock has risen from a falling wedge pattern.
AKAN
), an international medical cannabis company, has recently disclosed its participation in a registered direct offering priced at the Minimum Price under Nasdaq rules. The company has entered into a securities purchase agreement with an accredited investor for the acquisition of 2,491,381 common shares at a purchase price of $0.1031. Additionally, the investor will obtain 21,756,922 pre-funded warrants to purchase 21,756,922 common shares at $0.103 per share. The pre-funded warrants are immediately exercisable at an exercise price of $0.0001 and are subject to certain beneficial ownership limitations as outlined in the pre-funded warrant.
Technical Outlook
Akanda Corp. (NASDAQ:
AKAN
) stock is up 24.98% as of the time of writing with a bullish Relative Strength Index (RSI) of 66.87 which is slightly overbought. The stock has risen from a falling wedge pattern.
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Download our Mobile App >>
Android: dexwirenews.com/APP
Apple: dexwirenews.com/iOS
2) Join our Telegram >> t.me/DEXWireNews
3) Follow @DEXWireNews on Social Media
1) Download our Mobile App >>
Android: dexwirenews.com/APP
Apple: dexwirenews.com/iOS
2) Join our Telegram >> t.me/DEXWireNews
3) Follow @DEXWireNews on Social Media